My self-inserted photo to the women lab members to show my appreciation. Y’all rock!! Shay and Katie left a space in the middle to give a shout-out to the suffering Ukrainians!
Thrilled to announce BioTM’s new impact factor of 10.71. Huge thanks to our authors, reviewers, board members, and editorial team for reaching this milestone on the 5th anniversary of publishing the first issue @BioTM_Buzz @wileyinresearch@ChEnected@Aaron_Anselmo@profnance
“The funds from this Series B raise combined with the support of our partners from CPRIT provide the resources to operate our company for several years..." - @OncoNano CEO Martin Driscoll. See more coverage on the latest from OncoNano in @DallasInnovates. https://t.co/4gUR7FT1JI
The May cover illustrates that a polymeric STING agonist can prolong the activation of innate-immunity pathways via the formation of condensates.
https://t.co/Egv47yBD10
https://t.co/hqPbmZYsWj [Paper]
The effectiveness of cancer immunotherapies will benefit from a range of strategies — new, or borrowed from other classes of therapeutic — to trigger durable immune responses.
https://t.co/ciqSG3cRwt
In our open letter, we scientists are standing up for @Harvard professor Charles Lieber. We also are speaking out against the harm that the prosecution of Charles and other scientists has inflicted on academic freedom and scholarly collaboration.
Check out @IOTNmoonshot PI Dr. Jinming Gao @biotransistor & team @UTSWNews Feb.2021 article providing a proof of principle for new cancer immunotherapy strategies targeting the STING pathway.
A polyvalent STING agonist prolongs the activation of innate-immunity pathways through the formation of STING condensates, and leads to synergistic therapeutic outcomes in vivo when combined with the STING ligand cGAMP.
https://t.co/zgq0ZapgkZ
Our paper with @rahmioklu out today in @ScienceTM on using an ionic liquid agent LATTE for treating large hepatocellular tumors to help bridge more patients to liver transplantation https://t.co/988gWLuKw0 @MayoClinic@hseas@wyssinstitute@EdenTanner
A polyvalent STING agonist prolongs the activation of innate-immunity pathways through the formation of STING condensates, and leads to synergistic therapeutic outcomes in vivo when combined with the STING ligand cGAMP.
https://t.co/LFswrigBPv
Congrats to my labmate, Suxin, for this innovative study!
"Prolonged activation of innate immune pathways by a polyvalent STING agonist"
Published today in Nature Biomedical Engineering.
https://t.co/WgeTIFvsim